These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35793465)

  • 1. Immune complications and their management in inherited and acquired bleeding disorders.
    Arruda VR; Lillicrap D; Herzog RW
    Blood; 2022 Sep; 140(10):1075-1085. PubMed ID: 35793465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test.
    Mathieu S; Crampe C; Dargaud Y; Lavigne-Lissalde G; Escuriola-Ettingshausen C; Tardy B; Meley R; Thouvenin S; Stephan JL; Berger C
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):940-5. PubMed ID: 26517064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutics for hemophilia and other bleeding disorders.
    Callaghan MU; Sidonio R; Pipe SW
    Blood; 2018 Jul; 132(1):23-30. PubMed ID: 29769259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia A and von Willebrand deficiency: therapeutic implications.
    Basso M; Lazzareschi I; Curatola A; Di Gennaro L; Buonsenso D; Gatto A; De Candia E; De Cristofaro R
    Blood Coagul Fibrinolysis; 2020 Sep; 31(6):397-401. PubMed ID: 32255574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of autoimmune acquired coagulation factor deficiency].
    Ogawa Y
    Rinsho Ketsueki; 2023; 64(9):1116-1123. PubMed ID: 37899190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country.
    Ay Y; Ersin T; Yesim O; Hilkay KT; Dilek I; Gulcihan O; Ahmet K
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):729-31. PubMed ID: 26484639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerating Factor VIII: Recent Progress.
    Lacroix-Desmazes S; Voorberg J; Lillicrap D; Scott DW; Pratt KP
    Front Immunol; 2019; 10():2991. PubMed ID: 31998296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune tolerance induction in patients with hemophilia A.
    Astermark J
    Thromb Res; 2011 Jan; 127 Suppl 1():S6-9. PubMed ID: 21056905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?
    Valentino LA; Ozelo MC; Herzog RW; Key NS; Pishko AM; Ragni MV; Samelson-Jones BJ; Lillicrap D
    J Thromb Haemost; 2023 Nov; 21(11):3033-3044. PubMed ID: 37225021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.
    Oldenburg J; Austin SK; Kessler CM
    Haemophilia; 2014 Sep; 20 Suppl 6():17-26. PubMed ID: 24975701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune tolerance therapy in patients with acquired hemophilia.
    von Depka M
    Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of immune tolerance induction in hemophilia A.
    Schep SJ; Schutgens REG; Fischer K; Boes ML
    Blood Rev; 2018 Jul; 32(4):326-338. PubMed ID: 29482894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of VWF for the success of immune tolerance induction.
    Kreuz W
    Thromb Res; 2008; 122 Suppl 2():S7-S12. PubMed ID: 18549910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors.
    Kurth MA; Dimichele D; Sexauer C; Sanders JM; Torres M; Zappa SC; Ragni M; Leonard N
    Haemophilia; 2008 Jan; 14(1):50-5. PubMed ID: 17941829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010.
    Gringeri A; Ofosu FA; Grancha S; Oldenburg J; Ewing NP; Federici AB
    Haemophilia; 2012 May; 18(3):469-75. PubMed ID: 21943193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.